Peptidylglycine α‐amidating monooxygenase as a therapeutic target or biomarker for human diseases is a research paper published in British Journal of Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01‐DK032948
National Institutes of Health
Grant: R01‐DK032949
National Institutes of Health
Grant: R01‐GM125606
National Institutes of Health
Grant: R21‐GM140390
National Institutes of Health
Grant: R15‐GM073659
NIGMS NIH HHS
Grant: R15 GM067257
NIGMS NIH HHS
Grant: R21 GM140390
NIDDK NIH HHS
Grant: R01 DK032948
NIGMS NIH HHS
Grant: R01 GM125606
NIGMS NIH HHS
Grant: R15 GM073659
NIDDK NIH HHS
Grant: R01 DK032949
National Institutes of Health
Grant: 5R01GM125606-02
Peptide Amidation in Ciliogenesis
National Institutes of Health
Grant: 5R01DK032948-27
Cell Biology of Bioactive Peptide Secretion
National Institutes of Health
Grant: 1R15GM073659-01
Enzymatic Cleavage of the C-N Bond in Glycine
National Institutes of Health
Grant: 1R21GM140390-01
Tools and Methods for the Elucidation of Fatty Acid Amide Cell Signaling Pathways
National Institutes of Health
Grant: 2R01DK032949-24A1
BIOCHEMISTRY AND PHYSIOLOGY OF PEPTIDE AMIDATION
Eppley Foundation for Research
FWCI
1.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals